Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
04/10/2024 21:02
Altamira Therapeutics Ltd CYTO.O :
* ALTAMIRA THERAPEUTICS PROVIDES UPDATE ON NASDAQ LISTING
* ALTAMIRA THERAPEUTICS: GOT ON SEPT 30, A LETTER FROM
NASDAQ THAT
IT NO LONGER COMPLIED WITH RULE 5550(A)(2) OF NASDAQ'S LISTING
RULES
Source text for Eikon: ID:nGNX3F7N65
Further company coverage: CYTO.O
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering